AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Cashflows-From-Investing-Activities" stands at 2.88 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2023.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.70 Billion United States Dollars compared to the value the year prior.
The 1 year change is -1.70 Billion United States Dollars.
The 3 year change is 3.20 Billion United States Dollars.
The 5 year change is 2.38 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Cashflows From Investing Activities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Cashflows From Investing Activities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Cashflows From Investing Activities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Cashflows From Investing Activities | 317,433,206,677.55 |
![]() | Novartis AG - Other Cashflows From Investing Activities | 255,096,620,580.91 |